{"id":"oral-suspending-vehicle","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108661","moleculeType":"Unknown"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Oral Suspending Vehicle","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:58:58.104193+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:59:03.464788+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Oral Suspending Vehicle","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:59:03.826324+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108661/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:59:04.910859+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Suspending vehicles are excipient-based liquid formulations that prevent drug particles from settling or aggregating, ensuring consistent dosing with each administration. They typically contain thickening agents, surfactants, and stabilizers to maintain uniform particle distribution and improve palatability and bioavailability of poorly soluble drugs.","oneSentence":"An oral suspending vehicle is a pharmaceutical formulation designed to keep solid drug particles uniformly dispersed in a liquid medium for oral administration.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:58:55.131Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:59:06.493189+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05713877","phase":"PHASE2","title":"Melatonin for Treatment of Delirium in Critically Ill Adult Patients","status":"RECRUITING","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2023-02-01","conditions":"Delirium","enrollment":30},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":"Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)","enrollment":72},{"nctId":"NCT07280299","phase":"PHASE2","title":"Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Gain Therapeutics, Inc.","startDate":"2026-05-30","conditions":"Parkinson Disease","enrollment":111},{"nctId":"NCT06833320","phase":"PHASE1, PHASE2","title":"Propranolol Treatment for Postoperative Chylothorax","status":"RECRUITING","sponsor":"June Wu","startDate":"2025-09-09","conditions":"Postoperative Chylothorax, Congenital Heart Disease, Open Heart Surgery","enrollment":50},{"nctId":"NCT04874012","phase":"PHASE2","title":"Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes","status":"RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2021-06-12","conditions":"Diabetes Mellitus, Type 2","enrollment":94},{"nctId":"NCT05397665","phase":"PHASE2, PHASE3","title":"Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"Applied Therapeutics, Inc.","startDate":"2022-01-01","conditions":"Hereditary Neuropathy Caused by SORD Deficiency","enrollment":56},{"nctId":"NCT06776679","phase":"PHASE1","title":"A Study of How [14C]-BGB-16673 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Participants","status":"COMPLETED","sponsor":"BeiGene","startDate":"2025-01-24","conditions":"Healthy Volunteers","enrollment":8},{"nctId":"NCT02094365","phase":"PHASE2","title":"A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model","status":"COMPLETED","sponsor":"Alios Biopharma Inc.","startDate":"2014-03","conditions":"Respiratory Syncytial Virus Infections","enrollment":62},{"nctId":"NCT06003829","phase":"PHASE1","title":"A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-07-31","conditions":"Healthy","enrollment":12},{"nctId":"NCT04225897","phase":"PHASE2","title":"A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.","status":"TERMINATED","sponsor":"Pfizer","startDate":"2019-11-13","conditions":"Respiratory Syncytial Virus (RSV), Lower Resp Tract Infection","enrollment":51},{"nctId":"NCT04470752","phase":"PHASE2","title":"Capsaicin for Post-stroke Dysphagia","status":"UNKNOWN","sponsor":"Georg Kägi, MD","startDate":"2021-08-24","conditions":"Dysphagia, Late Effect of Stroke","enrollment":82},{"nctId":"NCT04735822","phase":"EARLY_PHASE1","title":"A Phase I Study to Evaluate the Taste of Belumosudil Oral Suspensions & Assess Relative Bioavailability","status":"COMPLETED","sponsor":"Kadmon Corporation, LLC","startDate":"2020-10-26","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT01336530","phase":"PHASE3","title":"Tepilta® Versus Oxetacaine, Antacids and Placebo","status":"TERMINATED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2011-04","conditions":"Radiation-induced Oesophagitis","enrollment":40},{"nctId":"NCT04507321","phase":"PHASE1","title":"Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2020-09-24","conditions":"HIV Infections","enrollment":5},{"nctId":"NCT04512963","phase":"PHASE1","title":"Phase I Study of Progerinin in Healthy Volunteers","status":"COMPLETED","sponsor":"PRG Science & Technology Co., Ltd.","startDate":"2020-08-24","conditions":"Hutchinson-Gilford Progeria Syndrome, Werner Syndrome","enrollment":64},{"nctId":"NCT01676636","phase":"","title":"Delivery Vehicles for Prenatal Calcium Supplementation","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2012-10","conditions":"Pregnancy","enrollment":149},{"nctId":"NCT03921723","phase":"PHASE1","title":"Dolutegravir Pediatric Liquid Formulation Study","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2019-05-07","conditions":"HIV Infections","enrollment":22},{"nctId":"NCT03634085","phase":"PHASE1","title":"Single Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of BDM-2 in Healthy Male Subjects.","status":"COMPLETED","sponsor":"Hivih","startDate":"2018-05-17","conditions":"Healthy","enrollment":16},{"nctId":"NCT01435824","phase":"PHASE2","title":"Bioavailability of Amoxicillin Dissolved in Human Milk","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2011-06","conditions":"Healthy","enrollment":16},{"nctId":"NCT00734539","phase":"PHASE3","title":"Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight","status":"COMPLETED","sponsor":"Daniel Benjamin","startDate":"2008-11","conditions":"Candidiasis","enrollment":362},{"nctId":"NCT00920556","phase":"PHASE2","title":"A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma","status":"TERMINATED","sponsor":"Sirtris, a GSK Company","startDate":"2009-03-30","conditions":"Multiple Myeloma","enrollment":24},{"nctId":"NCT01849991","phase":"PHASE1","title":"Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-09","conditions":"Gastrointestinal, Colic","enrollment":21},{"nctId":"NCT02615340","phase":"PHASE2","title":"Melatonin for Prevention of Delirium in Critically Ill Patients","status":"UNKNOWN","sponsor":"Mount Sinai Hospital, Canada","startDate":"2017-10-12","conditions":"Delirium","enrollment":69},{"nctId":"NCT02588521","phase":"PHASE1","title":"A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study","status":"COMPLETED","sponsor":"Alios Biopharma Inc.","startDate":"2015-08-31","conditions":"Influenza","enrollment":152},{"nctId":"NCT00297206","phase":"PHASE1","title":"A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-01-25","conditions":"Herpes Simplex","enrollment":36},{"nctId":"NCT01708174","phase":"PHASE2","title":"A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-05-06","conditions":"Medulloblastoma","enrollment":22},{"nctId":"NCT03126695","phase":"PHASE1","title":"A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-05-12","conditions":"Sickle Cell Disease","enrollment":44},{"nctId":"NCT00938275","phase":"PHASE1","title":"A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers","status":"COMPLETED","sponsor":"Sirtris, a GSK Company","startDate":"2009-01-20","conditions":"Diabetes Mellitus, Type 2","enrollment":20},{"nctId":"NCT00920803","phase":"PHASE1","title":"A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases","status":"COMPLETED","sponsor":"Sirtris, a GSK Company","startDate":"2008-08-19","conditions":"Neoplasms, Colorectal","enrollment":9},{"nctId":"NCT00933530","phase":"PHASE1","title":"A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers","status":"COMPLETED","sponsor":"Sirtris, a GSK Company","startDate":"2008-05","conditions":"Diabetes Mellitus, Type 2, Healthy Volunteer","enrollment":43},{"nctId":"NCT02446171","phase":"PHASE1","title":"A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-05","conditions":"Bioavailability, Healthy Subjects","enrollment":44},{"nctId":"NCT02161367","phase":"PHASE4","title":"Effect of Simethicone on Postoperative Ileus in Patients Undergoing Colorectal Surgery","status":"COMPLETED","sponsor":"McMaster University","startDate":"2014-10","conditions":"Postoperative Ileus, Ileus","enrollment":100},{"nctId":"NCT00006994","phase":"PHASE3","title":"S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat","status":"TERMINATED","sponsor":"SWOG Cancer Research Network","startDate":"2001-11","conditions":"Cancer-related Problem/Condition, Head and Neck Cancer, Pain","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL2108661"},"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ORA-Plus®"],"phase":"marketed","status":"active","brandName":"Oral Suspending Vehicle","genericName":"Oral Suspending Vehicle","companyName":"McMaster University","companyId":"mcmaster-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:59:06.493189+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}